How Much Does Spravato Cost? Insurance, Copays, and Self-Pay

Short answer: Spravato's price depends almost entirely on insurance. With coverage, which is genuinely achievable because Spravato is FDA approved, most insured patients pay roughly $10 to $250 per session, and the manufacturer's savings program can bring the medication cost to as low as $10 for eligible commercial plans. Without insurance, expect $1,000 or more per monitored session, with a first month commonly reaching $8,000 to $12,000. Here is the full picture, including where we fit in.

Why Spravato's cost math is different

Spravato, the esketamine nasal spray, holds full FDA approval for treatment-resistant depression and for depression with acute suicidal thinking, and that approval is the money story: unlike off-label IV ketamine, Spravato has a real insurance pathway. Coverage is not automatic, every major plan requires prior authorization documenting your diagnosis and prior antidepressant trials, but once approved, the economics transform, with average insured patients spending a few hundred dollars a month or less. The trade-offs sit elsewhere: a federally required REMS program means every dose is taken in a certified clinic with about two hours of post-dose monitoring, and dosing starts twice weekly before tapering.

The numbers, plan by plan

The typical landscape in 2026: commercially insured patients often land between $10 and $250 per session after prior authorization, and many qualify for the manufacturer's SPRAVATO withMe program, which can cut the medication copay to as low as $10 per treatment. Medicare covers Spravato under Part B, leaving roughly 20 percent coinsurance, around $140 to $240 per session, which a Medigap supplement can reduce toward zero. Medicaid coverage exists in most states, often at very low or no cost. Self-pay is the hard road: $600 to $900 for the medication per dose plus clinic administration and monitoring, commonly totaling $1,000 to $1,500 per session and $8,000 to $12,000 for the induction month.

Spravato or IV ketamine: the cost angle

The comparison we drew in ketamine versus Spravato gains a money dimension here. If your insurance approves Spravato, it will usually be the cheaper path out of pocket, sometimes dramatically so. If you are self-pay either way, IV ketamine is typically the better value, more precise delivery at a lower total than Spravato's uninsured price. And clinically, some patients simply respond better to one or the other, which no spreadsheet can settle in advance. The right move is knowing both numbers for your situation before choosing.

Where Ketamine Uplift fits

We now offer Spravato alongside our IV ketamine program, fully credentialed, which lets us walk both paths under one roof: helping you pursue prior authorization when Spravato and your insurance align, and offering our transparent, financed IV program when self-pay is the road, with FSA and HSA dollars and tax considerations softening either route. Spravato consultations are scheduling now; ask when you call.

This article is for educational purposes only and is not medical, insurance, or financial advice. Verify coverage details with your insurer.

The bottom line

With insurance, Spravato commonly costs $10 to $250 per session after prior authorization, with copay assistance available; without insurance, sessions run $1,000 or more. Coverage is the whole ballgame, and it is winnable with the right documentation. For help thinking through Spravato versus IV ketamine for your situation, and to get started with Spravato here, call (310) 280-4440.

Frequently asked questions

How much does Spravato cost with insurance? Most insured patients pay roughly $10 to $250 per session after prior authorization, and eligible commercial patients can use the manufacturer's savings program to bring the medication cost to as low as $10 per treatment.

How much does Spravato cost without insurance? Typically $600 to $900 for the medication per dose, plus clinic monitoring, commonly totaling $1,000 to $1,500 per session and $8,000 to $12,000 for the first month.

Does Medicare cover Spravato? Yes, under Part B, generally leaving about 20 percent coinsurance, roughly $140 to $240 per session, which Medigap supplements often reduce to near zero.

Why does Spravato require in-clinic monitoring? An FDA REMS safety program requires each dose to be administered in a certified clinic with about two hours of observation, which is part of each session's cost.